Insider: Chivukula Pad Chief Scientific Officer & COO - Arcturus Therapeutics Holdings Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 435,334 | 0 | 435,334 |
| Value | $8,841,633.54 | $0.00 | $8,841,633.54 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/15/2024 | DDS | 12,000 | Direct | COM | $20.76 | $249,121.20 | 435,334 |
| 06/05/2024 | DDS | 114 | Direct | COM | $45.00 | $5,130.00 | 447,334 |
| 06/03/2024 | DDS | 26,000 | Direct | COM | $40.01 | $1,040,234.00 | 447,448 |
| 03/25/2024 | DDS | 17,435 | Direct | COM | $35.02 | $610,573.70 | 473,448 |
| 03/19/2024 | DDS | 8,565 | Direct | COM | $35.01 | $299,839.24 | 490,883 |
| 11/01/2023 | DDS | 5,000 | Direct | COM | $18.72 | $93,601.50 | 499,448 |
| 10/02/2023 | DDS | 5,000 | Direct | COM | $25.61 | $128,061.50 | 504,448 |
| 09/01/2023 | DDS | 5,000 | Direct | COM | $31.45 | $157,263.50 | 509,448 |
| 08/01/2023 | DDS | 5,000 | Direct | COM | $34.91 | $174,550.00 | 514,448 |
| 07/14/2023 | DDS | 25,000 | Direct | COM | $35.01 | $875,250.00 | 519,448 |
| 07/03/2023 | DDS | 5,000 | Direct | COM | $28.75 | $143,750.00 | 544,448 |
| 06/01/2023 | DDS | 5,000 | Direct | COM | $27.16 | $135,800.00 | 549,448 |
| 05/11/2023 | DDS | 7,925 | Direct | COM | $30.24 | $239,652.00 | 554,448 |
| 05/10/2023 | DDS | 17,075 | Direct | COM | $30.00 | $512,250.00 | 562,373 |
| 05/01/2023 | DDS | 5,000 | Direct | COM | $25.93 | $129,650.00 | 579,448 |
| 04/03/2023 | DDS | 5,000 | Direct | COM | $25.38 | $126,900.00 | 584,448 |
| 03/06/2023 | DDS | 5,000 | Direct | COM | $16.07 | $80,350.00 | 589,448 |
| 01/04/2022 | DDS | 8,100 | Direct | COM | $40.00 | $324,000.00 | 594,448 |
| 12/16/2021 | DDS | 3,633 | Direct | COM | $40.00 | $145,327.63 | 602,548 |
| 12/08/2021 | DDS | 6,367 | Direct | COM | $40.00 | $254,680.00 | 606,181 |
| 11/01/2021 | DDS | 10,000 | Direct | COM | $44.41 | $444,100.00 | 612,548 |
| 10/01/2021 | DDS | 10,000 | Direct | COM | $44.36 | $443,600.00 | 622,548 |
| 09/01/2021 | DDS | 10,000 | Direct | COM | $55.86 | $558,600.00 | 632,548 |
| 08/03/2021 | DDS | 10,000 | Direct | COM | $40.07 | $400,700.00 | 642,548 |
| 04/01/2021 | DDS | 10,000 | Direct | COM | $42.95 | $429,500.00 | 652,548 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research